This Week's Biotech Catalysts
All FDA decisions, clinical trial readouts, and key events happening this week.
49
Total Events
1
PDUFA Dates
45
Trial Readouts
Monday
May 1113Tuesday
May 1224Olema Oncology Reports First Quarter 2026 Financial and Operating Results
Wednesday
May 1325Kamada Reports First Quarter 2026 Financial Results and Affirms 2026 Annual Guidance; Expecting Significantly Stronger Remainder of the Year
ThursdayToday
May 146Friday
May 1532Netarsudil 0.02%/latanoprost 0.005% ophthalmic solution Phase 3 Results Expected
Netarsudil 0.01%/latanoprost 0.005% ophthalmic solution Phase 3 Results Expected
Emtricitabine/tenofovir disoproxil fumarate (F/TDF) Phase 2 Results Expected
SHR2554; Chidamide analog tablets Phase 3 Results Expected
Saturday
May 16No events scheduled
Sunday
May 17No events scheduled
Receive a summary of upcoming biotech catalysts every Monday morning.
Why Track Weekly Biotech Catalysts?
Biotech stocks are driven by binary events - FDA decisions, clinical trial results, and regulatory milestones. Knowing which catalysts are coming this week helps investors prepare for potential volatility and trading opportunities.
Key Events to Watch
- PDUFA Dates: FDA target action dates for drug approvals
- Clinical Trials: Phase 1, 2, and 3 data readouts
- AdCom Meetings: FDA Advisory Committee votes
- Conferences: Medical conference presentations
Stay Informed
This page updates automatically as new events are added or outcomes are announced. Bookmark it or sign up for our weekly email digest to never miss an important catalyst.